预防痴呆风险人群的成本效益:一个范围审查和定性综合
1Alexander Braun, IMC University of Applied Sciences Krems, Krems, Austria, alexander.braun@fh-krems.ac.at.
The journal of prevention of Alzheimer's disease
|February 20, 2024
概括
通过多领域干预措施预防痴呆是具有成本效益的,特别是对于风险较高的个人和中年人群来说,这些人群需要解决生活方式因素. 这些计划显示了医疗保健成本节约的潜力.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 老年学是指老年学的学科.
背景情况:
- 由于成本上升,痴呆症对全球经济构成了重大挑战.
- 由于目前没有治愈方法,预防痴呆症对于降低医疗保健支出至关重要.
- 大约40%的痴呆病例与可修改的风险因素有关.
研究的目的:
- 为了评估痴呆症预防策略的成本效益,为处于风险的人群.
- 综合证据,以预防痴呆症的多领域干预措施的经济可行性.
主要方法:
- 使用PICO和系统搜索字符串进行了范围审查.
- 在四个数据库中进行了搜索:Medline,CINHAL,Business Source Complete和HEED.
- 七项研究从最初的3,629项研究中满足了纳入标准.
主要成果:
- 大多数多领域预防干预措施都显示出明显的成本效益.
- 获得的平均质量调整寿命年 (QALYs) 为0.08,每人平均干预成本为472.20欧元.
- 增量成本效益比率 (ICER) 的范围很广,表明经济结果的多样性.
结论:
- 针对高危人群的痴呆症预防计划通常具有成本效益和效率.
- 多模式预防策略提供节省成本的潜力,当目标人群是明确的定义.
- 通过解决生活方式因素来预防中年群体的痴呆症也在经济上是可行的.
更多相关视频
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
相关概念视频
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Preventive Healthcare Services
1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Levels of Health Promotion and Illness Prevention
12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
